Simultaneously, we investigated five kinds of the CETP haplotypes that were significantly associated with risk of dyslipidemia and normal control groups (A/T/A/A/T/C/A/G, p = 0.017, OR = 0.408, confidence interval (95% CI) = 0.190–0.874; A/T/A/A/T/T/G/A, p = 0.013, OR = 0.443, 95% CI = 0.229–0.858; G/G/A/G/C/C/G/G, p = 0.04, OR = 0.371, 95% CI = 0.138–0.995; G/G/C/G/C/C/A/G, p = 0.022, OR = 1.294, 95% CI = 1.038–1.615; G/G/C/G/C/T/G/G, p = 0.0004, OR = 2.723, 95% CI = 1.535–4.829). This evidence concerns the gene CETP and metabolic syndrome.